Document:

Document

Exhibit 10.2

Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.  In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K.

AMENDED AND RESTATED SUPPLY AGREEMENT

This Amended and Restated Supply Agreement (“Agreement”) is made and entered into as of June 1, 2020 (the “Effective Date”) by and between Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a corporation organized under the laws of The People’s Republic of China (hereinafter “Mindray”), and Heska Corporation, a corporation duly organized and existing under the laws of the State of Delaware with its principal business address at 3760 Rocky Mountain Ave, Loveland, CO 80538, United States and its Affiliates (hereinafter “Heska”). Heska and Mindray shall at times be collectively referred to herein as the “Parties” and individually as a “Party”.
WHEREAS, Heska is willing to purchase Products, the details of which are defined in this Agreement, from Mindray and Mindray is also willing to provide those Products to Heska with the terms and conditions hereinafter set forth.
WHEREAS, Heska and Mindray are parties to an Exclusive Supply Agreement dated February 1, 2016, as amended by the Amendment to Exclusive Supply Agreement dated January 1, 2017 (collectively, the “Original Agreement”).
WHEREAS, the Initial Term of the Original Agreement expired on December 31, 2019, however it automatically extended for successive Renewal Term according to the terms of the Original Agreement. The Parties now agree to terminate the Original Agreement as the date first above written and enter into this Agreement upon the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual promises and covenants herein, the Parties agree as follows:
1. Definitions
1.1 “Affiliate” shall mean, with respect to each Party (as hereinafter defined), any legal entity that is, directly or indirectly, controlling, controlled by or under common control with such Party. For purposes of this definition, a Party shall be deemed to control another entity if it owns or controls, directly or indirectly, more than fifty percent (50%) of the voting equity of the other entity, or directly or indirectly possesses the power to direct, or cause the direction of, the management and policies of such other entity by any means whatsoever.
1.2 BLANK
1.3 “Calendar Quarter” shall mean a period of three (3) consecutive calendar months commencing on· January 1, April 1, July 1 or October 1 during the Term of this Agreement.
1.4 “Calendar Year” shall mean each twelve (12) month period during the Term of this Agreement beginning on January 1 and ending on December 31.
1.5 BLANK.

1.6 “Confidential Information” means any proprietary or confidential information of a Party which may be disclosed to the other Party under this Agreement, including without limitation all prices, discounts or product specifications, customers, Customers, designs, software, software code, drawings, reports, interpretations, forecasts, plans, records, technical or other financial or business information of any kind, of a disclosing Party regarding the subject matter of this Agreement, together with any notes or other documents prepared by a receiving Party or others which reflect such information.
1.7 “Consumables” shall mean documentation, supplies, consumables, reagents, calibrator, fluids, tubes, tips, cups, and other supplies necessary or ordinarily beneficial in the ordinary course of installation, calibration, maintenance and use of the Analyzer Product(s). Mindray shall use all reasonable endeavors, acting in good faith to ensure Consumables only operate on Analyzer Products sold by Heska and ensure that no other reagents manufactured by or for Mindray shall operate on Analyzer Products sold by Heska; except, provided however, Mindray shall use all reasonable endeavors, acting in good faith to ensure non-reagent QC/Cal manufactured for Mindray by third party to operate on Analyzer Products only operate on Analyzer Products sold by Heska.

1.8 “Customer” shall mean the end user of the Products, where use of Products is limited to non-human subjects, within the Market, within the Territory, as defined below. Supply of the Products to Customer may include one or more transactions that include the involvement of a third party dealer or reseller of Heska (“Agent”), who facilitates the purchase and installation to the Customer solely for use within the Market within the Territory.
1.9 “DOA” shall mean dead on arrival, as used in Article 8.2 Non-Conformities and Acceptance.
1.10 “Improvements” means, individually and collectively, all discoveries, inventions, know-how, techniques, modifications , improvements, works of authorship, designs, data, and all proprietary rights therein or associated therewith (whether or not protectable under patent, copyright, trade secrecy or similar laws) relating to additions, enhancements, updates, alterations, modifications, derivative works or other changes to any Products sold by Mindray to Heska hereunder.
1.11 “Intellectual Property” shall mean all drawings, designs, models, specifications, documentation, software, firmware, user interfaces, inventions, designs, techniques, processes, business methods, customer information, marketing programs, distributor information, know-how, technology, mask­ works, copyrights, copyrightable materials, patents, trade secrets, software code, software schema, contractor contacts, sources, vendors, suppliers, and any other information or materials protected under any intellectual property laws in effect anywhere in the world, and any applications, registrations or filings relating thereto.
1.12 “Legacy Mindray Dealer” shall mean the third party in Spain with an executed and in force agreement as of January 1, 2020 with Mindray under which such third party has sold or is selling the Mindray Product five-part analyzer and associated consumables to veterinary customers in Spain.
1.13 “Market” shall be defined as the field of Veterinary Medicine; as defined as the practice of medicine on non-human subjects by licensed users, in good standing with licensing and governmental authorities, or persons duly and legally supervised by such licensed users or authorities, in accordance with laws and regulations governing the use of medical devices on non-human subjects, in all locations and facilities, including, but 

not limited to veterinary hospitals and clinics, zoos, breeding operations, feedlots, pharmaceutical facilities , research facilities, universities , veterinary teaching hospitals , and governmental agencies.
1.14 “Mindray Product” shall mean the Mindray manufactured hematology analyzer product noted in Annex A (BC5000vet).
1.15 “North America Agreement” shall mean that certain agreement between the parties dated September 1, 2013.
1.16 “Product” shall mean, as the case may be, the Analyzer Product(s) based on Mindray Product and modified to Heska brand and use per this Agreement, Consumable(s) based on Mindray product and modified to Heska brand and use per this Agreement, and Spare Part(s), as those terms are further described and defined in Annex A and elsewhere in this Agreement.
1.17 “QC/Cal” shall mean control and calibrator fluids listed in Annex B (3) “QC/Cal”.
1.18 “Service Exchange Pool” shall mean a pool of between ten (10) and twenty (20) Analyzer Products to be maintained by Heska during the course of the Agreement. Heska shall ship replacement Analyzer Products (“Service Exchange(s)”) from the Service Exchange Pool to Customers who have reasonably claimed that Analyzer Products are not working correctly, and such returned Analyzer Products will be serviced by Heska to then be made available as Service Exchange Pool Products.
1.19 “Spare Parts” shall mean service parts, installation parts, replacement parts, spare parts, and documentation related thereto that are necessary or ordinarily beneficial in the ordinary course of installation, calibration, maintenance, repair, provision of warranty support, and use of the Analyzer Product(s), including, without lin1itation, those spare parts identified on Annex A, as amended from time to time.

1.20 “Tail” shall mean the six (6) year period following expiration or earlier termination of this Agreement, during which Mindray will sell to Heska the Consumables and Spare Parts.
1.21 “Territory” shall mean the areas defined in Annex C, including “Exclusive Territory” and “Non­ exclusive Territory”.
1.22 Capitalized terms not defined in this Article 1 shall have the meaning set forth herein.
2. Purpose, Appointment and Acceptance
2.1 Specifications. The specifications for the Products are set forth in Annex A and will in no case be less than the specifications for Products delivered in the original Exclusive Supply Agreement, dated January 1, 2017, as amended. (“Specifications”).

2.2 Purpose. Subject to the terms and conditions of this Agreement, Mindray agrees to sell to Heska, and Heska agrees to purchase from Mindray, the Products in accordance with the Specifications, as each are or shall be defined in Annex A attached, in the Minimum Annual Total volume(s), as described in Section 5.1 and Appendix B, for resale or placement to Customers, in the Market, in the Territory.

2.3 Appointment and Acceptance. During the Term of this Agreement, as specified in Article 3.1, and subject to the conditions hereinafter, including but not limited to Article 6 below, 

Mindray hereby appoints Heska as its exclusive distributor (even as to Mindray) for the Products, to Customers, in the Market within the Exclusive Territory, and non-exclusive distributor for the Products, to Customers, in the Market, within the Non-Exclusive Territory, and Heska accepts such appointment. Each Party warrants and represents to the other Party that: (i) they have the right to enter into this Agreement, (ii) the terms of this Agreement are not inconsistent with other contractual obligations, expressed or implied, which they may have, (iii) by negotiating or entering into this Agreement, the representing Party is not breaching, violating, unlawfully altering, being induced or inducing others to interfere, halt, terminate, or otherwise modify any other contractual obligations, express or implied, which they may have with any other party, (iv) it is not a party to any agreement, litigation, or business relationship  that prevents  it from  carrying out its obligations  under this Agreement, (v) it has the right and full corporate power to enter into this Agreement, and (vi) as of the date of the Agreement, it is unaware of any actual, threatened, or pending litigation or claim that would prevent or impair it or its Affiliates from carrying out its obligations under this Agreement or would reasonably cause the other Party to be prevented from or have difficulties carrying out its obligations under this Agreement.

3. Term
3.1 This Agreement shall commence on the Effective Date and remain in effect until December 31, 2022 (the “Initial Term”); thereafter, Agreement shall automatically renew for successive two year periods (each a “Renewal Term”), unless sooner terminated in accordance with Article 15 of this Agreement (the Renewal Term together with the Initial Term, is collectively the “ Term”), provided, however, that Heska must meet the Minimum Annual Total in the prior Calendar Year. As discussed in Section 5.2. failure to meet the Minimum Annual Total in the prior Calendar Year may lead to termination of the Agreement. Notwithstanding the foregoing, however, the Term shall not exceed ten (10) years without the express written agreement of Mindray.
4. Purchase Orders & Product Packaging and Labeling
4.1 Orders. In placing purchase orders with Mindray, Heska shall detail the (i) Products (ii) quantity of each Product, and (iii) delivery date, which shall be at least sixty (60) days from the date of the purchase order (“Lead Time”). The orders shall be considered accepted and binding unless they are rejected by Mindray, provided that such acceptance shall not be unreasonably withheld and Mindray shall notify Heska within five (5) days if any order from Heska is rejected; provided, however, if Mindray is unable or unwilling to timely fulfill a purchase order that otherwise complies with all requirements set forth in this Agreement, Heska shall nonetheless be credited with such order quantity for purposes of the Minimum Annual Total requirements of Article 5 below. REGARDLESS OF FORM, EVERY PURCHASE ORDER, ORDER ACKNOWLEDGMENT, ORDER ACCEPTANCE OR INVOICE IS DEEMED TO INCLUDE THE APPLICABLE TERMS AND CONDITIONS OF THIS AGREEMENT AND ANY PRE-PRINTED OR OTHER TERMS AND CONDITIONS ASSOCIATED WITH SUCH FORM SHALL NOT BE APPLICABLE ABSENT MUTUAL WRITTEN AGREEMENT OF THE PARTIES. The order shall be, when fulfilled with Product, payable in full within sixty (60) days of shipment of the Product from Mindray.
4.2 Packaging and Labeling. Mindray shall supply all packaging and labeling required by Heska for Products in accordance with the Specifications on Annex A. All Product packaging and labeling shall be as set forth and agreed to in good faith in the Specifications in Annex A. It is intended that the Product packaging and labeling will be 

a full private label branding to Heska brands, marks, and packaging logos, without reference to Mindray. All labeling and packaging shall designate Heska as the exclusive “source” of the Products, and for those Products manufactured in whole or in part in China, using terminology of “manufactured for Heska in China” and shall include Heska’s logos and such other additional branding as shall be set forth in the Specifications. Mindray shall not acquire any right, title or interest in any of Heska’s trademarks and/or artwork, therein except for the purpose of manufacturing and packaging Products for Heska pursuant hereto. Heska shall be responsible for assuring that all Product packaging materials and labels comply with applicable laws in the Territory.
5. Minimum Purchase
5.1 Minimum Calendar Year Volume. Heska shall make purchases of Product from Mindray in such annual minimum quantities (“Minimum Annual Total”) as specified in Annex B. If Heska fails to make purchases equal to or greater to the Minimum Annual Total, the remedies in Section 5.2 shall apply.
5.2 Remedies for Volume Failure. If Heska fails to purchase the Minimum Annual Total (a “Minimum Purchase Failure”) within thirty (30) days of the end of the Calendar Year for which Mindray alleges Heska had a Minimum Purchase Failure, Mindray shall provide Heska written notice of such failure (a “Quantity Failure Notice”) and the following remedies in this Section 5.2 shall apply. If such Minimum Purchase Failure has not been cured by Heska within sixty (60) days after Mindray gives Heska written notice of such Minimum Purchase Failure, then Heska shall, in Heska’s sole discretion:
5.2.1 Pay Mindray, within thirty (30) days of receipt of the Quantity Failure Notice, an amount equal to five percent (5%) of the Average Transfer  Price (as determined by calculating the quotient of (a) the sum of all actual prices paid for the Analyzer Products purchased in the immediately prior two (2) Calendar Quarters, divided by (b) the actual number of Analyzer Products purchased in the immediately prior two (2) Calendar Quarters) multiplied by the Deficiency (as calculated by subtracting the number of Analyzer Products purchased by Heska in the Calendar Year from the Minimum Annual Total); In the event of two (2) Minimum Purchase Failures in consecutive years, Mindray may, on or before March 15th of the year immediately thereafter, terminate this Agreement upon ninety (90) days written notice. Or;
5.2.2 Terminate this Agreement. There are no other remedies for a Minimum Purchase Failure.

5.3 The Parties agree that they will make a mutually agreeable, good faith adjustment downward of the Minimum Annual Total from a period in which there was a Minimum Purchase Failure, if during such period; (i) Mindray was unable to deliver Products ordered on time, (ii) Mindray delivered to Heska a significant quantity of DOA Product, as defined in Article 8.2, or Products not meeting the Specification, iii) the Products were subject to a recall or other similar adverse event, or (iv) the Products, in the reasonable judgment of the Parties and a disinterested infom1ed observer, are no longer competitive in the Market, in the Territory.
6. Market, Territory, Exclusivity
6.1 Exclusivity Rights. Heska is granted the exclusive right to purchase the Products for sale, marketing and distribution in the “Market”, in the “Exclusive Territory”, to “Customers”, 

which right shall operate to exclude all others, including Mindray, its Affiliates and all third parties, and the non­exclusive right to purchase the Products for sale, marketing and distribution in the “Market”, in the “Non-exclusive Territory”, to “Customers” as each are defined in Article 1. In the Exclusive Territory in the Market, Mindray shall not, directly or indirectly through any third p arty, distributor, reseller or agent:
6.1.1 During the Term, sell or offer to sell, rent, loan, or lease the Products (or any modification, iteration, or derivation thereof) or any generic or similar in-clinic hematology analyzer products (5 part), or portions or subassemblies thereof, that are or could be competitive with the Products, that may be used by or sold to Customers in the Market within the Exclusive Territory (“Illicit Products”) .
6.1.2 During Tail Period, sell or offer to sell the Consumables or Spare Parts or any modification, iteration, derivation, or generic version thereof that are usable on Analyzer Product sold, placed, loaned or leased by Heska.
Heska shall not sell or offer to sell Products outside of the Territory or Market, except with Mindray’s prior written consent.
6.2 In the Market within the Non-exclusive Territory, Mindray maintains right to sell or offer to sell, rent, loan, or lease, directly or indirectly through Mindray, its Affiliates, and/or any third party, distributor, reseller or agent, the Mindray Product as noted in Annex A (BC5000vet) (including consumables, reagents and spare parts) (or any modification, iteration, or derivation thereof) or any generic or similar in-clinic hematology analyzer products (5 part), or portions or subassemblies thereof, that are or could be competitive with the Analyzer Products, that may be used by or sold to Customers for use within Non-exclusive Territory, so long as such analyzer products do not operate with Consumables and (ii) such reagents do not operate with Analyzer Products.
6.3 Mindray’s Efforts to Protect. Mindray shall undertake to protect Heska’s Exclusive Territory and Market. Upon receipt of notice of a violation of Territory and Market exclusive to Heska by a third party (or through an agent of such third party), Mindray shall with regard to such third party act to protect Heska’s Exclusive Territory and Market, including without limitation and as applicable, to the extent that permitted or allowed  by applicable laws (i) send a cease and desist letter, with a copy to Heska (ii) legally void warranty and software license on Illicit Product and notice third party of such void, with copy to Heska, (iii) demand from the third party responsible for sale(s) of the Illicit Product the disgorgement and payment to Heska of profits from the sale of Illicit Product(s) in Heska’s Market and Exclusive Territory, with copy of such demand to Heska, and (iv) immediately ceasing delivery of products that are, may be, or may become Illicit Products to such party or a party supplying such party with Illicit Products.
6.4 Exclusive Territory Protections by Mindray. Mindray undertakes to not knowingly allow any party to sell, lease, lend, demonstrate, market or solicit for business, directly or indirectly, a Product or Illicit Product to a Customer in the Market within the Exclusive Territory. For the Term of this Agreement, Mindray shall not, directly or indirectly, except exclusively through or for the benefit of Heska under this Agreement, sell, resell, lease, lend, or market: (i) the Products, (ii) portions or components of the Products, or (iii) products to which Mindray directly or indirectly benefits, controls, develops, or commercializes, that compete with the Products, to Customers in the Market within the Exclusive Territory. Mindray further undertakes not to sell in the Non-Exclusive Territory, any Consumables or Spare Parts for use on Analyzer Products sold or placed into service with Customers by Heska during the Term and during the Tail. Mindray will 

ensure Analyzer Products will not operate with reagents that are not Consumables sold to and through Heska.
6.5 No Export or Gray Market by Heska.  Heska undertakes not to sell, lease, lend, or participate in any way, directly or indirectly, through one or more relationships  or contracts, the Products or any products or services that contain, in whole or in part, the Products, for use, resale, export outside of the Territory or Market. Heska shall not directly or indirectly, and shall not authorize any other party to, sell, lease, lend, demonstrate, market or solicit for business any of the Products or products containing, in whole or in part the Products, outside the Market or Territory, including, without limitation, using commercially reasonable efforts so that Heska’s distributors and customers do not resell or otherwise distribute the Products outside of the Market or Territory.
6.6 Market Limited. Except as provided by the North American Agreement, Heska shall not sell, lease, lend, or participate in any way, directly or indirectly, through one or more relationships or contracts, the Products or any products or services that contain, in whole or in part, the Products, intended for use or for resale, demonstration, use or export outside of the Market or Territory, nor to any person, entity, or organization who is not a Customer or Agent selling directly to a Customer in the Market in the Territory. Heska and Mindray agree that all software and Products provided hereunder from Mindray to Heska shall be and are intended for use in the veterinary medical industry in the Territory.
6.7 Other Agreements In Effect. The terms in this Agreement apply solely to the Territory and Market as defined in Article 1 of this Agreement. Heska’s rights and obligations in territories and markets, as defined in other effective agreements between the two parties, including the North American Agreement, will not be affected by this Agreement. Nothing contained in this Agreement shall affect or alter the North American Agreement.
6.8 Protection of Mindray Property: Heska Customer Obligations. Heska shall protect all Mindray Intellectual Property and Confidential Information to the same degree it protects its own Intellectual Property and Confidential Information, but in no case less than exercising reasonable care.
6.9 Conclusion with Legacy Mindray Dealer. During the Term, Mindray may sell Mindray Product consumables that do not operate with Analyzer Product but are Illicit Products to Legacy Mindray Dealer and QC/Cal products, only for resale by Legacy Mindray Dealer directly and only to licensed veterinarian end users in Spain who (i) purchased Mindray Product five-part analyzer from Legacy Mindray Dealer prior to December 31, 2020 and (ii) are identified by name, address, and phone number to Mindray in writing by Legacy Mindray Dealer on or before December 31, 2020.
7. Price and Payment
7.1 Prices. The prices for the Products purchased by Heska hereunder shall be as set forth in the attached Annex B, unless otherwise agreed upon by the Parties in writing from time to time.
7.2 Net Amounts and Costs. All prices for the Products are “net amounts” in US Dollars. Unless otherwise expressly provided, Mindray is responsible for all insurance, freight, customs, duties, tariffs, any foreign, federal, state or local taxes that may be applicable to bring the Products to Heska’s dock, excluding VAT. Each Party shall be responsible for their own federal, state and local sales, use and income taxes and assessments, Value Added Taxes, and other taxes, fees, and duties.

7.3 Resale Tax Exemption. Heska agrees to provide to Mindray a copy of Heska’s Resale Tax Exemption Certificate for any sales within Heska’s Territory subject to resale tax exemption, otherwise, all applicable taxes will be included on the invoices.
7.4 Payment Instructions. Subject to offset for DOA Product as provided in Article 8.2 below, the full payment is immediately due and must be settled, within sixty (60) days of shipment of the Product(s) from Mindray, with payment by company check or wire transfer of immediately available funds, issued by a first class, international bank, satisfactory to Mindray at the following bank or a first class, international bank other financial institution as Mindray may designate that is reasonably satisfactory to Heska.
Bank: [***]
8. Shipment and Acceptance
8.1 Freight Terms. The Product prices are inclusive of Mindray performing and paying for delivery to Heska’s dock in Germany, France, Spain, Italy, or the United States, as directed by Heska, provided however that Heska agrees to be the importer of record in Germany, France, Italy, and Spain and pay VAT. Mindray will be responsible for any and all carriage, loading, unloading, charges, or other import/export cost, excluding VAT in the designated countries above, until the Products have arrived at Heska’s designated dock. Title shall transfer at Mindray’s dock and risk of loss for the Products shall pass to Heska upon delivery to Heska’ s dock. Notwithstanding the prior sentences, the Spare Parts and QC/Cal prices are based on Exworks (Incoterms 2010) United States. Mindray shall ship Product to Heska using reputable carriers, under Economy class shipment or better. The Parties shall cooperate in freight matters, including the prompt and complete documentation for proof of loss claims to an appropriate carrier and/or insurer. Heska shall photograph damage to original packaging, immediately upon receipt of packaging that Heska deems to have incurred external damage.
8.2 Non-Conformities and Acceptance. All claims for error, damages, defects, shortages and material non-conformities in any shipment discovered by reasonable inspection shall be made in writing to Mindray (together with detailed descriptions and evidence thereon) within thirty (30) days after receipt of the Products at Heska’s destination point shipping dock (such Products containing errors, damages, defects, shortages, and material non-conformities each, a “DOA Product”). Failure to make such claim within such period shall constitute acceptance of the shipment (“Acceptance”). The extent of Mindray’s liability for DOA Product under this warranty shall, at Heska’s option, be limited to: (i) replacement as herein provided of any defective Products, freight prepaid to Heska designated dock, or (ii) return of DOA Product(s), at Mindray’s sole expense, provided however, that Heska agrees to use reasonable efforts to repackage and make DOA Product(s) available for shipment in original packaging, or if damaged, in a manner consistent with Heska’s own packaging standards for similar products, for a full refund, to the extent Mindray was previously paid by Heska for such DOA Product, or for an offset against future invoices. Mindray shall have no liability for any defects in cases of damage arising from Heska’ s negligent handling.
9. Warranties
9.1 Limited Product Warranty.
9.1.1 Analyzer Product Warranty. Mindray warrants the Analyzer Products sold by Mindray conform to the Specifications and shall be free from defect in material and workmanship for (i) twenty-one (21) months from the date of Mindray’s shipment of the Products to Heska. Mindray and Heska agree that the exclusive 

remedies for Mindray’s breach of its limited express warranty is limited at Mindray’s election solely to: (a) the repair and/or replacement of the defective Analyzer Product or part, as reasonably determined by Mindray; or (b) refund of the purchase price and return the Analyzer Product; provided, however, that for DOA Products, the provisions of Section 8.2 shall apply. In fulfilling its limited warranty to repair and/or replace a defective Analyzer Product or part, Mindray shall use all reasonable endeavors, acting in good faith. The limited warranty does not extend to any of the Analyzer Products that have been, other than by Mindray: (1) subject to misuse, neglect, or abuse, (2) improperly repaired, or altered or modified, and/or (3) used in violation of instructions furnished by Mindray or in contravention of generally accepted usage standards in the Market, in the Territory, by Customers, for products similarl to Analyzer Products. Heska shall solely bear all costs to retrieve and to ship all Analyzer Product(s) requiring warranty service to Mindray designated location within the United States. Mindray shall solely bear all costs to ship all Analyzer Product(s) repaired under warranty service to Heska’s principal place of business.
9.1.2 Analyzer Products Needing Repair. Heska must maintain a Service Exchange Pool, with Service Exchanges, as defined in Article 1. Heska will make its commercially reasonable effort to troubleshoot and fix non-functioning Analyzer Products in the Territory. If the units in question cannot be brought by Heska up to normal functionality and operation according to Specification, Heska will then initiate the Analyzer Product limited warranty process with Mindray, as described in Section 9.1.1. Mindray will return the repaired units back to Heska’s Service Exchange Pool. Mindray shall reimburse or replace Spare Parts used by Heska in repairing units under warranty upon receipt of Heska’s written itemization of Spare Parts used in such repairs, itemized per repaired unit’s serial number.
9.1.3 Extended Warranty. Analyzer_Products must be covered by active warranty or extended warranty policies in order to be eligible for purchasing extended warranty for the next period.
9.1.4 Consumables Warranty. Mindray warrants the Consumables sold by Mindray conform to the Specifications as set forth in Annex A, shall work with the Analyzer Product for the intended purpose, shall have a shelf life of at least fifteen (15) months, except for probe cleanser shall have a shelf life of at least eight (8) months, from receipt by Heska, and shall be free from defect in material and workmanship. Mindray will cover the replacement of the non-conforming or defective Consumable(s).
9.2 Repair-Replace Warranty. Mindray warrants its repair work and replacement parts for a period of ninety (90) days from return to Heska (or other location directed by Heska) of the repaired or replaced Analyzer  Product or for the balance of the warranty period as set forth in Article 9 “Warranty”, whichever is longer. Mindray and Heska agree that the exclusive remedy for Mindray’s breach of its limited express warranty concerning repair work and replacement parts is limited solely to the repair and/or replacement of the Analyzer Product or part, as reasonably determined by Mindray. In fulfilling its limited warranty to repair and/or replace a defective Analyzer Product or part, Mindray shall act in good faith, time of the essence. Any claim arising under this Article 9 shall be settled by amicable cooperation between Mindray and Heska, to minimize or avoid unnecessary expense and time.

9.3 No Infringement. Mindray represents and warrants that neither the Products nor their manufacture, use, importation or sale infringe upon the proprietary rights held by a third party in the Territory. In the event of an allegation of infringement of any third party intellectual property rights is made, or in Mindray’s and Heska’s opinions is likely to be made, in respect of the Product Mindray may at its own expense (i) obtain for Heska and its customers the right to continue to import, sell and use the Product, (ii) modify the Product so as to avoid infringement in a way reasonably acceptable to Heska or (iii) if conditions (i) and (ii) cannot be complied with on terms which in Mindray’s opinion are reasonable, Mindray (x) may terminate this Agreement upon not less than ninety (90) days’ advance notice, and (y) shall indemnify Heska according to the provisions of Section 13.2 of this Agreement. If the Agreement is tem1inated pursuant to this Section 9.3 Mindray shall, at its cost, use its best efforts to identify a mutually acceptable manner of modifying the Product or this Agreement to render the Product or the performance of this Agreement non-infringing and, upon Heska’s request, accept return of and refund monies paid for Product in Heska’s inventory. Heska shall have the right of first refusal for a period of thirty-six (36) months following such termination before Mindray may appoint any new distributor in the Territory.
9.4 Disclaimer of All Other Warranties. EXCEPT FOR THE LIMITED WARRANTY EXPRESSLY SET FORTH IN THIS AGREEMENT, MINDRAY HEREBY DISCLAIMS ALL OTHER WARRANTIES, EXPRESS, STATUTORY OR IMPLIED, WITH RESPECT TO THE PRODUCTS, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.
10. Governing Law; Dispute Resolution; Exclusive Venue and Jurisdiction
10.1 The English language employed herein shall be controlling and this Agreement shall not be governed by the United Nations Convention on Contracts for the International Sale of Goods. Any claim or controversy relating in any way to this Agreement shall be governed by and interpreted exclusively in accordance with laws of England and Wales without regard to the conflicts of law principles thereof. Any dispute arising out of or relating to this Agreement, shall be finally settled under the Rules of Arbitration of the International Chamber of Commerce by three arbitrators appointed in accordance with the said Rules. The language of arbitration shall be English. The place of arbitration shall be London, UK. The award rendered by arbitrator(s) shall be final binding upon the Parties hereto.
10.2 Mindray represents and warrants to Heska that Mindray has the authority to enter into this Agreement and to bind itself to the obligations set forth herein. Mindray shall not assist, permit or cause any Affiliate to take any action which, if taken by Mindray, would constitute a breach of this Agreement, and Mindray shall use its best efforts to prevent any Affiliate from taking any such actions. Heska represents and warrants to Mindray that Heska has the authority to enter into this Agreement on behalf of, and to bind, each and all of its Affiliates to the obligations set forth herein.
11. Parties’ Responsibilities
11.1 HESKA’S RESPONSIBILITIES:
11.1.1 Marketing and Promotion of Product. Heska, at its sole discretion, shall undertake for its own account advertisement and sales promotions of the Products in the Market within the Territory. Heska shall use reasonably commercial efforts to market and sell the Products to Customers in the Market throughout the Territory.

11.1.2 Communication with Customers. Heska shall provide all warranty, technical support, shipping, and communications to and between Heska’s Customers, on the one hand, and Heska on the other, without, unless previously authorized between Heska and Mindray, any direct communication or obligations between Mindray and Heska’ s Customers. The identification of Heska Customers is Heska Confidential Information.
11.1.3 Sales Agents. Heska shall be solely responsible for selection, training, and support of installation personnel, technical support personnel, dealers, agents, sales representatives and contractors and for the advice performance of such persons under Heska’s direction and control in providing information and services to end user customers and Customers of the Products purchased hereunder.
11.1.4 Customer Use Restrictions. Heska shall reasonably undertake to train and to support Customers using the Product as to the proper use, installation, maintenance, and safety precautions necessary for the Product(s) proper perfom1ance and maintenance of good working condition.
11.1.5 Forecast. Heska, on a rolling basis, during the first ten (10) days of each Calendar Quarter after the Effective Date, shall, upon Mindray’s written request, provide Mindray with a written forecast of estimated purchases of the Products for the next twelve (12) month period. The forecast shall represent Heska’s commercially reasonable good-faith estimate of its Product requirements for such twelve (12) month period. Such forecasts are for the convenience of Mindray only, and shall not constitute firm purchase orders or shipping orders and shall not be binding upon or create any obligation or liability with respect to Heska. Mindray shall, within ten (10) days of becoming aware that Mindray may reasonably be unlikely to have the ability to fulfill the forecast quantities and schedule.
11.2 MINDRAY’S RESPONSIBILITIES:
11.2.1 Spare Parts and Consumables Tail. During the Tail period, Mindray shall maintain the capability to repair the Products, to deliver Consumables, and to deliver Spare Parts to Heska at terms at least as favorable as Mindray offers to any other customer(s) of Mindray in the Market and in the Territory, but in no case less favorable than the Price and terms of this Agreement, or at Mindray’s then-current price, whichever is lower; provided however, that the Price of this Agreement during the Tail may be adjusted pursuant to the Currency Rate Adjustment procedures in Section 7.5. During the Tail period, Heska shall have the exclusive right to sell Consumables and Spare Parts to Customers acquired by Heska from Effective Date through Termination.

11.2.2 Modifications and New Versions. Mindray reserves the right to make changes to any manufacturing source, controlled process parameters or sources and materials used with respect to the production of any of the Products and to otherwise reasonably modify any of the Products; provided that Mindray will provide Heska with at least one-hundred-eighty (180) days written notice of any major, material changes in the form, fit, performance, or function of any of the Products, along with details of such changes, and such major, material changes shall not adversely affect the performance, the Specification, the ability of Spare Parts and Consumables to operate on the Analyzer Products, or the sales prospects of the Product to Customers in the Market in the Territory. For any minor, changes, Mindray will use all reasonable endeavors, acting in good faith to provide Heska 

with at least ninety (90) days written notice of such changes, or as soon as practicable in line with Mindray’s standard change notification practices, provided however that such minor changes shall not adversely affect the performance, the Specification, the ability of Spare Parts and Consumables to operate on the Analyzer Products, or the sales prospects of the Product to Customers in the Market in the Territory.
11.2.3 In the event Mindray replaces or updates a Mindray Product or Product, for minor improvements to the form, fit, performance or functionality, Heska shall be entitled to acquire such updated or replaced version under the same terms of this Agreement in effect before such update or replacement. Pricing and relevant terms and conditions for (i) new products sold by Mindray that Heska reasonably deems appropriate for sale to Customers in the Market within in the Territory, and (ii) for the Mindray Products or Products that undergo major improvements in form, fit, performance or functionality shall be negotiated in good faith by the Parties. Mindray represents and warrants to Heska as of the Effective Date and throughout the Term and during the Tail, the prices, benefits and other terms and conditions in this Agreement are no less favorable to Heska than any other similarly situated customer or Affiliate of Mindray of similar purchase, sales, or placement of Mindray Products or similar products volume in the Market and in the Territory. The foregoing sentence will not restrict Mindray from transferring Mindray Products between Mindray Affiliates at Mindray’s intercompany transfer prices, as determined by Mindray.
11.2.4 Technical Assistance. For technical assistance, Mindray shall supply Heska with a reasonable amount of informative and illustrated materials regarding the Products. Mindray shall train a reasonable number of Heska’s technical personnel, at Heska’s and Mindray’s corporate address or other mutually agreed to location, scheduled by consent of both Parties, if it becomes necessary to achieving better installation and maintenance standards or to release new Products which may be added to the Products Schedule. Each Party shall bear its own costs in providing or receiving such training. Technical assistance is by and between Mindray and Heska, for the benefit of Heska, not the Heska’s Customers. The number of Heska personnel to be trained and the frequency of such trainings shall be agreed upon in good faith.
11.3 RESPONSIBILITIES OF BOTH PARTIES:

11.3.1 Government Approvals. The Parties shall be responsible for obtaining and maintaining all regulatory approvals and any amendment or supplements required, if any, to fulfill their own obligations hereunder specifically, plus, (i) in the case of Mindray, those necessary to provide for the manufacture, import, delivery, and sale of the Products in the Territory in the Market, and (ii) in the case of Heska, to receive, market, sell and service the Products in the Territory in the Market.

11.3.2 Regulatory Inquiries. Each Party shall promptly inform the other Party of the existence and substance of any inquiry or investigation related to Products initiated by any government authority or certification agency.

11.3.3 Regulatory Inspections and Information. To the extent required by law or at its reasonable discretion, Mindray and Heska shall each permit all governmental authorities and certification agencies the reasonable right to inspect their respective facilities at which the Products or any components of them are handled, 

stored, or shipped, and all records related to them. Both Parties shall reasonably assist such governmental authorities and certification agencies with such inspections. Each Party shall promptly notify the other of all such inspections related to or affecting the Products, and shall use reasonable efforts to provide the other Party the opportunity to be present at such inspections and shall use all reasonable endeavors, acting in good faith, to comply with governmental authority or certification agency requests for one Party to produce information that is confidential in nature to the disclosing Party, such as Customer contact information and location of Products; Confidential Information and Intellectual Property and provided pursuant to this Article 11.3.3 shall be used solely for the strict and limited purpose of complying with the governmental authority or certification agency requests or mandates, and shall not be used by the receiving Party for any commercial use, and shall be protected under Article 14 and Article 12 of this Agreement.

11.3.4 Product Complaints/Reports. Each Party shall promptly provide the other Party notice of any information regarding real or potential defects and complaints about the Products or would reasonably be considered material to the safety of them for their intended use. Each Party shall reasonably cooperate with the other in sharing any information that may constitute a complaint related to the Products. Mindray will use reasonable efforts to assist Heska in investigating and correcting any problems Heska or its Customers may experience with the Product. Such efforts will include qualified representatives of Mindray visiting the Territory when deemed reasonably necessary by Heska. ·Heska will use reasonable efforts to in1plement any corrective action recommended by Mindray.

11.3.5 Recalls. Mindray shall bear all costs and have sole authority and obligation to declare a recall of any Products, if Mindray believes that there is a potential significant health hazard or non­compliance with applicable government regulations. In the event that a mandatory recall, withdrawal or modification of the Product is required by a decision or ruling of a court of competent jurisdiction or by a ruling or regulation of a governmental agency (“Mandatory Recall”), or in the event of a voluntary recall initiated by Mindray, Mindray shall be responsible for supplying modified Products or components thereof, to Heska for Heska’s delivery to Customers who purchased such Product, consistent with applicable regulations and/or government agency instructions or rulings. In connection with any recall, Heska will implement the recall and supply the affected Customers with modified Products or components and/or service, where applicable, thereof under the direction of Mindray. Mindray and Heska agree to work cooperatively to facilitate any recall. In connection with this obligation, Heska shall track serial numbers of all Product delivered to customers at the time of delivery. Mindray shall reimburse Heska for reasonable expenses incurred by Heska pursuant to this Article 11.3.5.

11.3.6 Laws. Each Party will at its own expense comply with all applicable international, national, state, regional, and local laws, rules, and regulations of competent public authorities relating to its duties, obligations, any applicable quality processes, regulatory compliance and performance under this Agreement. Heska has sole responsibility for determining that no applicable laws of the Territory within the Market prohibits, limits or materially impairs in any respect the sale and distribution of the Products for the intended purpose.

12. Proprietary Rights
12.1 Intellectual Property.
12.1.1 Each Party retains all rights to its Intellectual Property pre-existing as of the Effective Date of this Agreement. Except as provided for expressly in this Agreement, no license, right or ownership is granted, by implication or otherwise, to a Party’s Intellectual Property.  As of the date of this Agreement, neither Party claims any rights to, or ownership in, the other Party’s Intellectual Property, and neither Party claims the existence of any jointly owned Intellectual Property between the Parties. In the event either Party provides the other Party with such other Party’s data regarding certain veterinary parameters, such information shall be provided pursuant to the Confidential Information rights in Article 14.
12.1.2 Mindray owns all Intellectual Property rights in the Products, and shall own all Improvements thereto, except for the Confidential Information of Heska. In the event that any Intellectual Property rights in the Products or any Improvements vest in Heska, Heska hereby assigns to Mindray all right, title, and interest in such Intellectual Property rights to Mindray, and shall fully cooperate with Mindray, at Mindray’s expense and for reimbursement of Heska’s reasonable related expenses, in executing all documents required to confirm the foregoing assignment.
12.1.3 During the Term of this Agreement, and subject to Heska’s compliance with the terms of this Agreement, Mindray hereby grants to Heska (i) an exclusive (even as to Mindray) non­transferable, non-sublicenseable (other than as permitted under Section 12.6) license under Mindray’s Intellectual Property embodied in the Products solely for the purpose of selling the Products to Customers in the Market within the Exclusive Territory and (ii) a non-exclusive, non­transferable, non-sublicenseable (other than as permitted under Section 12.6) license under Mindray’s Intellectual Property embodied in the Products solely for the purpose of selling the Products to Customers in the Market within the Non-Exclusive Territory. For avoidance of doubt, the exclusivity of the license granted herein shall extend only to the Market within the Territory.
12.1.4 During the Term of this Agreement, Heska hereby grants to Mindray a non-exclusive license under Heska’s Intellectual Property embodied in Heska’s trademarks solely for the purpose of manufacturing and providing the Products to Heska pursuant to the terms of this Agreement.
12.2 No Unauthorized Use. Neither Party shall use the other Party’s Intellectual Property or Confidential Information for any purpose other than to advance the sale of the Products by Heska to Customers in the Market within the Territory.
12.3 No Right. Except as expressly set forth herein, neither Party is granted any right to the other Party’s software or Intellectual Property, even if the software, hardware, or firmware is incorporated into any products, software, or other Intellectual Property. Nothing herein, or in any way related to this Agreement or interaction or non-action or delay between the Parties or their assigns, shall grant, transfer, or cause to be shared, with the other Party, any rights in and to either Party’s software, in any form, firmware, designs, component sources and specifications, documentation, or Intellectual Property. This Section 12.3 shall apply, whether or not either Party or any third party products are incorporated in, embedded in, merged with, or otherwise associated with a Party’s products.

12.4 Software License Definition. Certain licenses may be provided, included, or bundled with Products, including but not limited to HL7, networking, and other interfaces and software for displaying, capturing, transmitting or synchronizing data to and from the Analyzer Product (the “Software”).

12.5 Software License. Heska is hereby granted a non-exclusive, fully-paid-up, perpetual, irrevocable license to license, install, use and support the Software solely in connection with the sale of Products to Customers in the Market within the Territory according to the terms hereunder (the “License”). Software is protected by copyright, trademark, and trade secrets laws, international treaty provisions and various other intellectual property laws. Heska shall not, and shall use reasonable commercial efforts to ensure that each Customer does not, (i) use the Software for other than Customer’s internal business purposes, (ii) permit any third parties to use the Software other than as expressly permitted by this Agreement, (iii) reverse engineer, decompile, disassemble, or otherwise attempt to discover the source code of any Software, (iv) modify the Software in any manner, (v) use the Software in the operation of a service bureau, (vi) copy the Software, except that Heska may make copies of the Software for regulatory reasons and in furtherance of support and warranty of the Products, or (vii) use the Software other than in conjunction with the Products sold hereunder, or in any manner not expressly authorized by this Agreement. The Software’s component parts may not be separated either from each other or from the other Product components for any use. Where the Software is end user readable, the Software will be private labeled to Heska’s brand; provided, however, that any copyright notices, other ownership notices, or other legal notices embedded in the Software shall remain in the name of Mindray.
12.6 Right to Sublicense. During the term of this Agreement, Heska may sublicense to Customers, for use in the Market within the Territory, the nonexclusive and personal right to use, in object code format only, the Software for the life of the Products associated with such Software. Such sublicense shall be granted consistent with the terms of Section 6.6 of this Agreement.

12.7 Ownership; Rights. Neither Party shall acquire any right, title or interest in any of the other Party’s trademarks, copyrights, trade names, nor other intellectual property and proprietary information, except as specifically granted in this Agreement. No rights are granted to Heska under this Agreement to make or cause to be made any of the Products.
13. Insurance and Indemnity
13.1 Insurance. Mindray shall at its sole cost and expense maintain throughout the Term: (i) Workers’ Compensation insurance as required by all applicable laws; and (ii) product liability insurance coverage affording protection for bodily injury, death, personal injury and property damage caused by or due to default of the Products, and including coverage for contractual liability and products liability, with minimum coverage limits of [***] per occurrence, and minimum coverage limits of [***] in the aggregate. Any product liability insurance policy of Mindray covering the Products shall name Heska as an additional insured. If applicable law requires Mindray to maintain higher coverage limits or other insurance coverage, then such required limits or insurance shall be satisfied. Mindray hereby covenants to obtain all insurance as required under the terms of this Section 13.1 from a reputable, licensed insurance provider with a financial strength rating of “A-” or better by S&P. Upon written request by Heska, Mindray shall deliver to Heska, one or more certificate(s) of insurance evidencing such coverage. The policies required to be maintained by Mindray under this Section 13.1 shall be primary and non-contributory. With respect to any policies or coverage maintained on a “claims-made” basis, such 

policies shall be maintained for a period of not less than two years following the expiration of the Term. Notwithstanding anything to the contrary, the contractual liability in 13.l(ii) shall be limited to maximum amounts implied by law and the liability is assumed by Mindray under any warranty under the requirement of Federal or State legislation governing product safety.
13.2 Indemnification by Mindray. Mindray agrees to defend, indemnify and hold harmless Heska and its Affiliates, and each of their respective directors, officers, agents, investors and employees, from any and all losses, claims, damages, awards, penalties, expenses or injuries incurred by Heska, including reasonable attorney’s fees and all court costs, arising out of or resulting from: (a) any third party claims alleging that the Products infringe any copyright, patent, trade secret, trademark, or other proprietary right of any third party; or (b) any third party claims the Products cause bodily injury (including death), or physical damage to tangible property and/or such injury or damage resulted in reputational harm to such third party; or (c) any third party claim that this Agreement, including the negotiation or implementation of this Agreement, or the appointment of Heska by Mindray to sell Products to Customers in the Market within the Territory violates or interferes with (i) any agreement between any third party and Mindray or (ii) any alleged legal duty, express or implied, allegedly owing from Mindray to a third party. The foregoing indemnity applies only if the instructions outlined in the Product’s labeling, manual, and/or instructions for use are followed. This indemnification does not apply to liability and/or damages arising from: (1) an injury due to the negligence of any person other than an employee or agent of Mindray; (2) the failure of any person other than an employee or agent of Mindray to follow any instructions for use of the Product; or (3) the use of any product not purchased from Mindray, or Product that has been modified, altered, reprocessed, or repaired in a manner inconsistent with Mindray published instructions or specifications, where such modification, alteration, reprocess, or repair can be shown to be a material contributor to such liability and/or damages for which indemnification is claimed. Mindray shall have the sole right to defend such claims covered under this indemnification, at its own expense, and Heska shall, at Mindray’s expense, use reasonable efforts to provide such assistance in investigating and defending such claims as Mindray may reasonably request. This indemnity shall survive the expiration or termination of this Agreement.

13.3 Indemnification by Heska. Heska agrees to defend, indemnify and hold harmless Mindray and its Affiliates and each of their respective directors , officers, investors and employees, from any and all losses, claims, damages, awards, penalties, expenses or injuries incurred by Mindray, including reasonable attorney’s fees and all court costs, arising out of or resulting from: (a) any third party claims alleging that the Products as a result of marking by Heska infringe any trademark of any third party; or (b) any third party claims alleging that this Agreement, including the negotiation or implementation of this Agreement , or the appointment of Heska by Mindray to sell Products to Customers in the Market within the Territory violates or interferes with (i) any agreement to which Heska is a party or (ii) any alleged legal duty, express or implied, allegedly owing from Heska to any such third party; or (c) any third party claim arising from Heska’s purchase, marketing, sale, distribution, service, or support of the Products; or (d) Heska’s breach of this Agreement. Heska shall have the sole right to defend such claims covered under this indemnification, at its own expense, and Mindray shall, at Heska’s expense, use reasonable efforts to provide such assistance in investigating and defending such claims as Heska may reasonably request. This indemnity shall survive the termination of this Agreement.

14. Confidential Information
14.1 Confidentiality. No Confidential Information disclosed by either Party to the other in connection with this Agreement shall be disclosed to any person or entity other than the receiving Party’s employees and contractors directly involved with the receiving Party’s use of such information. Such information shall be used only for the purposes contemplated by this Agreement, and such information shall otherwise be protected by the receiving Party from disclosure to others with the same degree of care accorded to its own proprietary information, but not less than a reasonable degree of care in accordance with the normal practice of the medical device development industry. To be subject to this provision, information must be delivered in writing and designated as “proprietary” or “confidential” or, if initially disclosed orally or visually, must be confirmed in writing as “proprietary” or “confidential” within thirty (30) days after the disclosure. Information will not be subject to this provision if it (i) is or becomes a matter of public knowledge without the fault of the receiving Party, (ii) was known to the receiving Party before the disclosure to it by the other Party, as evidenced by written records of the receiving Party, or (iii) was received by the receiving Party from a third person under circumstances permitting its unrestricted disclosure by the receiving Party. If the receiving Party is required by law, or requested by a court or administrative body, to disclose any Confidential Information of the disclosing Party, the receiving Party shall give the disclosing Party prior written notice of such requirement or request prior to disclosing such Confidential Information so that the disclosing Party may seek a protective order or other appropriate relief.
14.2 Confidentiality Release. The Parties shall be released from any confidentiality obligations under this Article 14 five (5) years after the last of any and all of the obligations of the Parties to this Agreement have expired; provided, however, that with respect to any trade secrets disclosed by a Party, the confidentiality obligations under this Article 14 shall survive for as long as such confidential information remains a trade secret.
15. Termination
15.1 Right to Terminate for Good Cause. A Party has the right to tem1inate this Agreement for Good Cause with immediate effect. “Good Cause” means the occurrence of one or more of the following events:
(a) Should one of the Parties become bankrupt or insolvent, or have its business placed in the hands of a receiver, assignee or trustee, whether by voluntary act or otherwise, or become unable to pay its bills in the ordinary course of business, on time; or
(b) If one of the Parties ceases to function as a going concern or to conduct its operations in the normal course of business; or
(c) A Party becomes unable, due to regulatory sanction or claim or loss of license or regulatory approval, to meet its commitments under the Agreement.
15.2 Right to Terminate for Breach with Notice. This Agreement may be terminated by either Party if the other Party materially breaches any material provision of this Agreement and fails to cure such breach within sixty (60) days of written notice by the non-breaching Party describing the material breach (“Notice Period”). Each Party agrees to work with the other, in good faith, in connection with a Party’s efforts to cure any breach.

15.3 Termination During Renewal Term. This Agreement may be terminated by either Party during the Renewal Term upon not less than 180 days prior to the expiration of the then current Renewal Term upon notice to the other Party.
15.4 Effect of Termination. In the event of termination by Mindray for Good Cause pursuant to Section 15.1 or resulting from a breach by Heska pursuant to Section 15.2 above or following the effective date of termination by Heska pursuant to Section 15.3, all undisputed monies owed to Mindray shall become due and payable. Following the expiration of the Term or earlier termination of this Agreement as permitted by Article 15 of this Agreement, Mindray shall have no right to require Heska to continue to act as a distributor of the Products, and Heska shall have no right to require Mindray to continue to sell the Products to Heska; provided. however, that Mindray shall be obligated; (i) to fulfill warranty on Products for the full term of such warranty under this Agreement prior to termination and to sell to Heska and fulfill extended warranty obligations hereunder and during the Tail so that Heska can meet its commitments to Customers who have purchased and paid for (or contractually promised to pay for), through Heska, warranty and service products, including as provided for in Article 9, and Annex B and (ii) to sell Replacement Parts and Consumables to Heska under the Tail, including as provided for in Section 11.2. Each of the Parties acknowledges that it is acting independently in connection with any actions taken in connection with this Agreement, including any investments in personnel, facilities, and marketing activities undertaken hereunder, and is not relying on any express or implied representation or promise from the other Party that this Agreement will continue for any period except as expressly provided herein. Each of the Parties hereby waives any claim against the other for loss or damage of any kind (including, without limitation, damages or other compensation for unjust enrichment, loss of prospective profits, lost business opportunities, rein1bursement for expenditures or investments made or commitments entered into or goodwill) because of the termination of this Agreement for any reason as permitted by Article 15 of this Agreement or failure of Heska to extend the term beyond the Initial Term of this Agreement or because of failure of the Parties, for whatever reason, upon expiration hereof,  to make a similar agreement.
16. General Provisions
16.1 Assignment. Either Party may assign their rights or delegate or subcontract their duties under the Agreement to affiliates without written consent of the other party; provided, however that assigning Party shall remain responsible for all performance and obligations under the Agreement. This Agreement shall be binding on and shall inure to the benefit of each Parties’ successors and assigns. Heska may assign this Agreement to: (i) any of its majority owned Affiliates; or (ii) any person or entity that acquires substantially all of the business or assets of Heska or substantially all of the business segment relating to the Products that are the subject of this Agreement; provided, however, Mindray shall have the right to terminate this Agreement and enter Tail Period within sixty (60) days of receipt of notice of assignment if such assignment is (a) to a person or entity that manufactures a competitive product to tl1e Products, or (b) Zoetis, Inc., or (c) IDEXX, Inc.
16.2 Force Majeure. Mindray shall not be liable for, or be deemed to be in default for, delay of or failure in delivery or performance of any other act under this Agreement due directly to any of the following causes; acts of God or the public enemies, civil war, insurrection or riot, fires, floods, explosions, earth quakes or serious accident, epidemics or quarantine restrictions, or any act of government or military authority. Promptly upon 

the occurrence of any event hereunder which may result in all delay in the delivery of the Products, Mindray shall give notice thereof to Heska, which notice shall identify such occurrence and specify the period of delay which may reasonably be expected to result therefrom.
16.3 Survival of Obligations. Notwithstanding any provision to the contrary contained in this Agreement, the provisions of Articles 6.8, 9, 10, 11.2.1, 12, 13, 14, 15.4 and 16, and other terms that by their nature are intended to survive termination, shall survive the expiration or termination of this Agreement and continue to be enforceable in accordance with their respective terms.
16.4 Notices. Except as otherwise provided herein, any notice or other communication from one Party to the other Party shall be in writing, deemed effective upon receipt and either delivered in person or sent via internationally recognized overnight carrier, United States certified mail, or facsimile (upon confirmation of delivery thereof) and addressed as follows, or to such other address as the addressee shall have specified by notice hereunder from time to time:
If to Heska:

Heska Corporation Attn: President
3760 Rocky Mountain Ave.
Loveland, CO 80538

Copy to:

Heska Corporation 
Attn: Legal Department
3760 Rocky Mountain Ave.
Loveland, CO 80538

If to Mindray:

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Attn: Legal Department
Mindray Building, Keji 12th Road South High-Tech Industrial Park
Nanshan, Shenzhen 518057 P.R. China

Copy to:

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 
c/o North American Corporate Counsel
800 MacArthur Blvd.
Mahwah, NJ 07430

16.5 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Signatures transmitted by facsimile or other electronic means are acceptable the same as original signatures for execution of this Agreement.
16.6 Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be unenforceable because it is invalid or in conflict with any law of any 

relevant jurisdiction, the validity of the remaining provisions shall not be affected, and the Parties agree that the court making the determination of unenforceability shall have the power to reduce the scope, duration, or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the judgment may be appealed.
16.7 Compliance with Laws. Each Party to this Agreement shall comply with all applicable laws and regulations relating to the Products and their respective performance under this Agreement.
16.8 No Partnership or Agency. Nothing in this Agreement shall be construed as creating a partnership, agency, employment relationship, franchise relationship or taxable entity between the Parties. The relationship established by this Agreement is that of independent contractors, and nothing contained in this Agreement shall be construed to (i) give either Party the power to direct and control the day-to-day activities of the other, (ii) constitute the Parties as partners, joint ventures, co-owners, or otherwise as participants in a joint or common undertaking, or (iii) allow either Party to create or assume any obligation on behalf of the other for any purpose whatsoever, except as expressly authorized under this Agreement. All financial obligations associated with the business of each respective Party are the sole responsibility of that respective Party.
16.9 Entire Agreement. This Agreement constitutes the entire understanding of the Parties relating to the subject hereof and supersedes all other previous agreement and understandings, whether written or oral.
16.10 Interpretation; Headings. Articles and other headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretations of this Agreement. This Agreement is the result of arms-length negotiations between the Parties hereto and no provision hereof, because of any ambiguity found to be contained therein or otherwise, shall be construed against a Party by reason of the fact that such Party or its legal counsel was the draftsman of that provision.

IN WITNESS WHEREOF, this Agreement has been duly executed as of the date specified above.

HESKA CORPORATION SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:

By:     /s/ Kevin Wilson                  By:         [***]              

Name:     Kevin Wilson                   Name:         [***]              

Title:     CEO, President                  Title:     GM, Global VET    
Annex A – Product & Product Specifications

Analyzer Product
Name and main function
Mindray product name: BC-5000vet (“Mindray Product”)
OEM product name:  Element HT5 (“Analyzer Product”)

BC-5000vet and Element HT5 is an automatic veterinary 5-part differential hematology analyzer.

Net Size / Net Weight
						
	Net Size/ Net Weight	[***]
	HxWxD (cm)	[***]
	Weight (Kg)	[***]

Throughput and Parameters
At least [***] samples per hour Dog, Cat, Horse, Ape/Monkey, Ferret, Rat, Mouse, Bovine, Goat, Llama and Sheep.
Aspiration volume: ≤ [***] ul
Parameters:
WBC, Neu#, Lym#, Mon#, Eos#, Bas#, Neu%, Lym%, Mon%, Eos%, Bas%
RBC, MCV, HGB, HCT, MCH, MCHC, RDW%
PLT, MPV
Display and Software
Color touch screen: ≥ 10.1’’
Software updates directly through USB drive.
Embedded operation system.
Communication and Interface
LAN Port supports HL7 protocol
USB, LAN
Support LIS – Bi-Directional Communication

Linearity
												
	Parameter	Unit	Linearity Range	Display Range
	WBC	[***]	[***]	[***]
	RBC	[***]	[***]	[***]
	MCV	[***]	[***]	[***]
	HGB	[***]	[***]	[***]
	HCT	[***]	[***]	[***]
	PLT	[***]	[***]	[***]

Background
									
	Parameter	Unit	Background Limits
	WBC	[***]	[***]
	RBC	[***]	[***]
	HGB	[***]	[***]
	PLT	[***]	[***]

Carryover

[***]

The calculated carryovers shall meet the requirements in the following table:
						
	Parameter	Carryover
	WBC	[***]
	RBC	[***]
	HGB	[***]
	PLT	[***]

Reproducibility [***]

						
	Parameter	CV%
	WBC	[***]
	RBC	[***]
	MCV	[***]
	HGB	[***]
	PLT	[***]

Consumables 
Diluent, DIFF lyse, LH lyse listed in Annex B (2) “Consumables” (shelf-life is [***] months)
Probe cleanser (shelf-life is [***] months) listed  in Annex B (2) “Consumables”
Shelf-life is counted from the manufacturing dates.
QC/Cal listed in Annex B (3) “QC/CAL”

Spare Parts
Not to exceed the principal of manufacturing cost plus [***].

Annex B – Price & Minimum Quantity

Price
															
					
	1.	Analyzer Product Price in Territory:            $[***]			
	2.	Consumables			
	 P/N
		Description		Heska Transfer Price
	[***]		EHT5 Diluent(OEM/5.5L×2)		 $ [***]
	[***]		EHT5 Diluent(OEM/20L×1)		 $ [***]
	[***]		EHT5 DIFF LYSE(OEM/300mL×4)		 $ [***]
	[***]		EHT5 LH LYSE(OEM/90mL×4)		 $ [***]
	[***]		Probe Cleanser(OEM/25mL×6)		 $ [***]

												
				
	3.	QC/Cal		
	P/N		Description	Heska Transfer Price
	[***]		EHT5 Control_CBC-5DMR Vet Normal pack (2 x 3.0mL  - Normal Level )	 $ [***]
	[***]		EHT5 Control_CBC-5DMR Vet Tri-Pack  (12 x 3.0mL – 4 of each level  Low, Normal, High)	 $ [***]
	[***]		EHT5 Cal_CBC-CAL PLUS Vet  Calibrator set (1 x 3.0mL)	 $ [***]

						
		
	4.	Spare Parts
		a. Not to exceed actual manufacturing cost plus [***].
b. The Spare Parts prices are based on Exworks (Incoterms 2010) Mahwah, NJ USA. Spare Parts are shipped to Heska US facilities only.

	5.	Extended Warranty (per unit per year of Extended Warranty)
		a. [***] of the Analyzer Product Price

Minimum Annual Total
Calendar Year 2020: [***] Analyzer Product units purchased by Heska or its affiliates under this Agreement or any agreement.
Calendar Year 2021: [***] Analyzer Product units purchased by Heska or its affiliates under this Agreement or any agreement.
Calendar Year thereafter: [***] Analyzer Product units purchased by Heska or its affiliates under this Agreement or any agreement.

Analyzer Product units purchased by Heska exceeding a Calendar Year’s Minimum Annual Total will be credited to commitment of next year’s Minimum Annual Total.
				
		

Annex C: Territories
Exclusive Territories:
Albania
Andorra
Austria
Bosnia & Herzegovina
Belgium
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Iceland
Ireland
Italy
Japan
Kosovo
Latvia
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malta
Moldova
Monaco
Montenegro
Netherlands
Norway
Portugal
San Marino
Slovakia
Slovenia
Spain
Sweden
Switzerland
Ukraine
United Kingdom (Including Scotland, N Ireland, Wales, England)
Spain will be an Exclusive Territory of Heska after December 31, 2020

Non-Exclusive Territories
Rest of World; excepting: i) Mainland China which is not part of any Territory for Heska; and ii) United States, Canada and Mexico which are not part of any Territory under this Agreement and shall be covered by North America AgreementDocument

.3

Exhibit 10.3

EMPLOYMENT AGREEMENT
This Employment Agreement (the “Agreement”) is made effective on 4/16/2020, 2020 (the “Effective Date”) between Heska Corporation, a Delaware corporation (“Heska”), and Steve Eyl (“Executive”). Heska and Executive collectively are referred to as the “Parties” and individually as a “Party.” 
RECITALS

WHEREFORE, Executive is currently the Executive Vice President, Chief Commercial Officer, Heska and President, scil animal care company, a wholly-owned subsidiary of Heska.

WHEREFORE, Executive and Heska now wish to enter into this Agreement regarding the terms of Executive’s employment, which shall become effective upon execution.

NOW, THEREFORE, in consideration of the foregoing and of the mutual promises, covenants, and agreements contained herein, the legal sufficiency of which is acknowledged by the Parties, and intending to be legally bound, the Parties agree as follows:

TERMS

1. Duties and Scope of Employment.

a. Position and Duties. As of 4/16/2020, 2020, Executive will serve as Executive Vice President, Chief Commercial Officer, Heska and President, scil animal care company. Executive will render such business and professional services in the performance of Executive’s duties, consistent with Executive’s position within Heska and/or its subsidiaries, as will reasonably be assigned to Executive by Heska’s Board of Directors, Chief Executive Officer, or Executive’s supervisor. Executive’s duties will be subject to review and adjustments will be made at the discretion of the Executive’s supervisor and superiors.

b. Obligations. During the Term of Agreement (as defined below), Executive will devote Executive’s full attention, skills, time and business efforts to Heska and/or its subsidiaries. For the duration of the Term of Agreement, Executive agrees not to actively engage in any other employment, occupation, or consulting activity, for any direct or indirect remuneration, without the prior approval of the Board or the Corporate Governance Committee of the Board; provided, however, that Executive may, without the approval of the Board or the Corporate Governance Committee of the Board, serve in any capacity with any civic, educational, or charitable organization, provided such services do not interfere with Executive’s obligations to Heska.

.3

2. Term of Agreement.
a. The period of Executive’s employment under this Agreement is referred to herein as the “Term of Agreement.” Subject to the provisions for earlier termination of employment in Section 6 below, this Agreement will have an initial term of twelve (12) months commencing on the Effective Date. On the 1st anniversary of the Effective Date, and on each annual anniversary of the Effective Date thereafter, this Agreement automatically will renew for an additional twelve-month term unless Heska provides Executive with notice of non-renewal at least 120 days prior to the date of automatic renewal; provided, however, that either Heska or Executive may terminate Executive’s employment immediately at any time subject to the provisions in Section 6 below.

b. Executive may be entitled to severance benefits pursuant to Section 6 below, depending upon the circumstances of Executive’s termination of employment. Upon the termination of Executive’s employment for any reason, Executive will be entitled to payment of all expense reimbursements, and other benefits due to Executive through Executive’s termination date under any Heska-provided or paid plans, policies, and arrangements. Executive agrees to resign from all positions that Executive holds with Heska and its subsidiaries, without limitation, immediately following the termination of Executive’s employment if the Board so requests.

3. Compensation.

a. Base Salary. Heska will pay Executive an annual salary of $350,000.00 as compensation for Executive’s services (the “Base Salary”). The Base Salary will be paid periodically in accordance with Heska’s normal payroll practices and will be subject to the usual, required withholdings and deductions. Executive’s salary will be subject to review, and adjustments will be made at the sole discretion of the Compensation Committee of the Board (the “Committee”) and based upon Heska’s standard practices.

b. Annual Bonus. During the Term of Agreement, Executive will be eligible to
participate in the Management Incentive Plan (“MIP”), a compensation plan intended to reward near term performance (i.e. no longer than the coming year) which may be available from time to time at the discretion of the Committee. MIP Payouts, if any, will accrue and become payable in accordance with the Committee’s standard practices for paying executive incentive compensation, provided, however, that any bonus payable under this subsection will be payable within two-and-one-half (2-1/2) months after the end of the taxable year to which it relates or such longer period as may be permitted or required by Treasury regulations in order to avoid application of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) to such MIP Payouts. Any MIP Payouts paid pursuant to this Section will be subject to applicable withholdings and deductions.

.3

4. Expenses.
a. In addition to the foregoing, Heska will reimburse Executive for Executive’s reasonable out-of-pocket travel, entertainment, and other expenses, in accordance with Heska’s expense reimbursement policies and practices in effect at the time of the reimbursement request. Executive shall submit such requests within forty-five (45) days of incurring such expenses.

5. Employee Benefits.

a. During the Term of Agreement, Executive will be eligible to participate in the benefits offered to other executives of Heska, in accordance with benefit plans, policies, and arrangements that may exist from time to time.

6. Termination and Severance.

a. Termination without Cause or for Good Reason other than In Connection with a Change of Control. If, at any time, Executive’s employment is terminated by Heska without Cause (as defined below) or pursuant to Heska’s delivery of notice of non- renewal pursuant to Section 2(a) above, by Executive for Good Reason (as defined below), or due to Executive’s death or Disability (as defined below), and the termination is not In Connection with a Change of Control (as defined below), Executive will receive the following, subject to conditions and limitations set forth in Section 7:

i. A payment of an amount equal to six (6) months of Executive’s Base Salary, payable in accordance with Heska’s standard payroll practices over the shorter of the following periods (A) in equal installments over the period beginning on the date of such termination and ending on the one-year anniversary thereof, or (B) in equal installments on a monthly basis corresponding to the amount Executive would normally receive as salary each month if Executive were still employed with Heska, with a lump sum of any remaining balance of the amount specified above on March 15 of the year following the year of termination.

ii. Provided that, within thirty (30) days of termination date, Executive elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), Heska shall pay the COBRA premium for coverage for Executive and Executive’s eligible dependents under Heska’s Benefit Plans (as defined below) for six (6) months, or if earlier, until Executive becomes employed by another employer and eligible for coverage under such other employer’s welfare benefit plans (e.g., payments for medical COBRA premiums will cease when Executive becomes eligible for another employer’s medical plan.) For the balance of the period during which Executive and Executive’s eligible dependents are 

.3

entitled to coverage under COBRA, Executive shall be entitled to maintain coverage for Executive and Executive’s eligible dependents at Executive’s sole expense.
Executive shall notify Heska immediately upon Executive’s acceptance of employment with another employer.

b. Termination without Cause or for Good Reason In Connection with a Change of Control. If, at any time, Executive’s employment is terminated by Heska without Cause or by Executive for Good Reason or pursuant to Heska’s delivery of notice of non-renewal pursuant to Section 2(a) above, and the termination is In Connection with a Change of Control (as defined below), then, subject to the limitations set forth in this Section 7, Executive will receive:

i. A payment of an amount equal to twelve (12) months of Executive’s Base Salary, payable in equal installments in accordance with the standard payroll schedule over the shorter of the following periods (A) the period beginning on the date of such termination and ending on the one-year anniversary thereof, or (B) the period beginning on the date of such termination and ending on March 15 of the year following the year of termination.

ii. Provided that, within thirty (30) days of termination date, Executive elects continuation coverage under COBRA, Heska shall pay the COBRA premium for coverage for Executive and Executive’s eligible dependents under Heska’s Benefit Plans (as defined below) for twelve (12) months, or if earlier, until Executive becomes employed by another employer and eligible for coverage under such other employer’s welfare benefit plans (e.g., payments for medical COBRA premiums will cease when Executive becomes eligible for another employer’s medical plan). For the balance of the period during which Executive and Executive’s eligible dependents are entitled to coverage under COBRA, Executive shall be entitled to maintain coverage for Executive and Executive’s eligible dependents at Executive’s sole expense. Executive shall notify Heska immediately upon Executive’s acceptance of employment with another employer.

c. Termination without Good Reason; Termination for Cause. If, at any time, Executive’s employment with Heska terminates voluntarily by Executive without Good Reason or is terminated for Cause by Heska, then (i) all further vesting of Executive’s outstanding equity awards will terminate immediately, (ii) all payments of compensation by Heska to Executive hereunder will terminate immediately (except as to amounts already earned), but Executive will be paid all expense reimbursements, and other benefits due to Executive through Executive’s termination date under any Company-provided or paid plans, policies, and arrangements, and (iii) Executive will not be entitled to any severance.

.3

d. Excise Tax. In the event that any benefits payable to Executive pursuant to Section 6 of this Agreement (“Termination Benefits”) (i) constitute “parachute payments” within the meaning of Section 280G of the Code, or any comparable successor provisions, and (ii) but for this Section 6(d), would be subject to the excise tax imposed by Section 4999 of the Code, or any comparable successor provisions (the “Excise Tax”), then Executive’s Termination Benefits hereunder shall be either (A) provided to Executive in full, or (B) provided to Executive as to such lesser extent which would result in no portion of such benefits being subject to the Excise Tax, whichever of the foregoing amounts, when taking into account applicable federal, state, local, and foreign income and employment taxes, the Excise Tax, and any other applicable taxes, results in the receipt by Executive, on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under the Excise Tax. Unless Heska and Executive otherwise agree in writing, any determination required under this Section 6(d) shall be made in writing in good faith by Heska’s independent accountants. In the event of a reduction of benefits hereunder, Executive shall be given the choice of which benefits to reduce. If Executive does not provide written identification to Heska of which benefits Executive chooses to reduce within ten (10) days after written notice of the accountants’ determination, and Executive has not disputed the accountants’ determination, then Heska shall select the benefits to be reduced. For purposes of making the calculations required by this Section 6(d), the accountants may make reasonable assumptions and approximations concerning the applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code and other applicable legal authority. Heska and Executive shall furnish to the accountants such information and documents as the accountants may reasonably request in order to make a determination under this Section 6(d). Heska shall bear all costs the accountants may reasonably incur in connection with any calculations contemplated by this Section 6(d).

7. Conditions to Receipt of Severance; No Duty to Mitigate; Covenants.

a. Separation Agreement and Release of Claims. The receipt of any severance pursuant to Section 6 will be subject to Executive signing and not revoking a confidential separation agreement and release of claims in a form reasonably acceptable to Heska. Such agreement will provide (among other things) that Executive will not disparage Heska, its affiliates, parents, subsidiaries, directors, executive officers, employees, agents, or representatives. No severance will be paid or provided until the confidential separation agreement and release agreement becomes effective. No severance will be paid or provided if the Executive’s confidential separation agreement and release agreement is not signed and irrevocable within forty-five (45) days after the Executive’s termination date. If Executive's date of termination and the last day of any applicable statutory revocation period could fall in two separate taxable years, regardless of when Executive actually executes and delivers the release, payments will not commence until the later taxable year.

.3

b. Non-Competition. In the event of a termination of Executive’s employment that would entitle Executive to the receipt of severance pursuant to Sections 6(a) or 6(b), or a termination for Cause by Heska, Executive agrees not to engage in Competition (as defined below) for six (6) months following the termination date. The geographic scope of this Section 7(b) is the United States of America and Europe. If Executive engages in Competition within such period, all continuing payments and benefits to which Executive otherwise may be entitled pursuant to Section 6 will cease immediately.

c. Non-Solicitation. In the event of a termination of Executive’s employment that would entitle Executive to the receipt of severance pursuant to Sections 6(a) or 6(b), or a termination for Cause by Heska, Executive agrees that, for twelve (12) months following the termination date, Executive, directly or indirectly, whether as employee, owner, sole proprietor, partner, director, member, consultant, agent, founder, co-venturer, or otherwise, (i) will not solicit, induce, or influence any person to modify his or her employment or consulting relationship with Heska (the “No-Inducement”), and (ii) not intentionally divert business away from Heska by soliciting business from any of Heska’s customers and users who would otherwise have placed the solicited order with Heska (the “No Solicit”). The geographic scope of this Section 7(c) is the United States of America and Europe. If Executive breaches the No-Inducement or No Solicit, all continuing payments and benefits to which Executive otherwise may be entitled pursuant to Section 6 will cease immediately.

d. Remedies. In the event of Executive’s breach of Sections 7(b) or 7(c), Heska shall have any and all remedies available to it in law or in equity, including without limitation the right to seek recovery of any amounts paid under Section 6 of this Agreement and injunctive relief, specific performance, or any other equitable relief to prevent a breach and to secure the enforcement of this Section. Injunctive relief may be granted immediately upon the commencement of any such action, and Heska need not post a bond to obtain temporary or permanent injunctive relief.

e. No Duty to Mitigate. Executive is under no duty or requirement to mitigate the amount of any payment contemplated by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such payment.

8. Definitions.

a. Benefit Plans. For purposes of this Agreement, “Benefit Plans” means plans, policies, or arrangements that Heska sponsors (or participates in) and that immediately prior to Executive’s termination of employment provide Executive and Executive’s eligible dependents with medical, dental, or vision benefits. Benefit Plans do not include any other type of benefit (including, but not limited to, financial counseling, disability, life insurance, or retirement benefits). A requirement that Heska provide Executive and Executive’s eligible dependents with coverage under the Benefit Plans will not be satisfied unless the coverage is no less favorable than 

.3

that provided to Executive and Executive’s eligible dependents immediately prior to Executive’s termination of employment.

b. Cause.  For purposes of this Agreement, “Cause” shall mean the occurrence of one or more of the following: (i) conviction of, or an entry of a plea of nolo contendere to, any crime (including one involving moral turpitude), whether a felony or misdemeanor, or any crime which reflects so negatively on Heska to be detrimental to Heska’s image or interests, or any act of fraud or dishonesty that has such negative reflection upon Heska; (ii) the repeated commitment of insubordination or refusal to comply with any reasonable request of Heska’s Board of Directors, Chief Executive Officer, or Executive’s supervisor related to the scope or performance of Executive’s duties; (iii) possession of any illegal drug on Heska premises or being under the influence of illegal drugs or abusing prescription drugs or alcohol while on Heska business, attending Heska-sponsored functions, or on Heska premises; (iv) the gross misconduct or gross negligence in the performance of Executive’s responsibilities which, based upon good faith and reasonable factual investigation of the Board, demonstrates Executive’s unfitness to serve; (v) material breach of Executive’s obligations under this Agreement; or (vi) material breach of any fiduciary duty of Executive to Heska or its subsidiaries,; provided, however, that if any occurrence under subsections (ii), (iv), (v), and (vi) is reasonably capable of being cured, Heska will provide notice to Executive describing the nature of such event and Executive will thereafter have thirty (30) days to cure such event, and if such event is cured within that 30-day period, then grounds will no longer exist for terminating Executive’s employment for Cause; and provided, further, that such cure period will not apply to any subsequent occurrence of the same event.

c. Change of Control. For purposes of this Agreement, “Change of Control” means (i) a sale of all or substantially all of Heska’s assets, (ii) any merger, consolidation, or other business combination transaction of Heska with or into another corporation, entity, or person, other than a transaction in which the holders of at least a majority of the shares of voting capital stock of Heska outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding or by their being converted into shares of voting capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of Heska (or the surviving entity) outstanding immediately after such transaction, (iii) the direct or indirect acquisition (including by way of a tender or exchange offer) by any person, or persons acting as a group, of beneficial ownership or a right to acquire beneficial ownership of shares representing a majority of the voting power of the then outstanding shares of capital stock of Heska, (iv) a contested election of Directors, as a result of which or in connection with which the persons who were Directors before such election or their nominees cease to constitute a majority of the Board, or (v) a dissolution or liquidation of Heska.

d. Competition. For purposes of this Agreement, Executive will be deemed to have engaged in “Competition” if Executive, without the written consent of the Board or 

.3

an authorized officer of any successor company to Heska, directly or indirectly (1) provides services or assistance in any form to any individual, entity, or company providing veterinary products for the companion animal health industry or imaging products or services for the veterinary market (a “Restricted Company”), whether such services or assistance is provided as an employee, consultant, agent, corporate officer, director, or otherwise or (2) participates in the financing, operation, management, or control of, a Restricted Company. A Restricted Company includes, without limitation, Zoetis, Inc. Abaxis, Inc. (currently a wholly-owned subsidiary of Zoetis, Inc.), IDEXX Laboratories, Inc., Sound Technologies, Inc. (currently a unit of Mars, Incorporated), and Zoetis, Inc. Notwithstanding the foregoing, nothing contained in this Section 8(d) or in Section 7(b) above shall prohibit Executive from being employed or engaged in a corporate function or senior management position (and holding commensurate equity interests) in a division of a Restricted Company, so long as such division is not in any way engaged in providing veterinary products for the companion animal health industry or imaging products or services for the veterinary market and Executive does not directly or indirectly provide services or assistance to any division that does provide veterinary products for the companion animal health industry or imaging products or services for the veterinary market.

e. Disability. For purposes of this Agreement, “Disability” shall mean that, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, the Executive either (i) is unable to engage in any gainful activity, or (ii) is receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Heska employees.

f. Good Reason.

i. For purposes of this Agreement, “Good Reason” means the occurrence of any of the following without Executive’s express written consent:

A. Executive’s officer level with Heska is, or Executive’s duties or responsibilities are, materially diminished relative to Executive’s officer level, duties, and responsibilities as in effect immediately prior to such change;

B. a material diminution in Executive’s Base Salary as in effect immediately prior to such diminution; provided, that an across-the- board reduction in the base compensation and benefits of all other executive officers of Heska by the same percentage amount (or under the same terms and conditions) as part of a general base compensation reduction and/or benefit reduction shall not constitute such a qualifying material diminution;

.3

C. a material change in the geographic location of Executive's principal place of employment such that the new location is greater than fifty (50) road miles each way from Executive's place of employment on the Effective Date;

D. any material breach by Heska of any provision of this Agreement; and

E. any acquiring company fails to assume or be bound by the terms of this Agreement In Connection with a Change of Control;

ii. The aforementioned occurrences shall not be deemed Good Reason unless Executive gives Heska written notice of the existence of the condition which Executive believes constitutes Good Reason (which notice must be given within ninety (90) days of the initial existence of the condition) and such condition remains uncured for a period of thirty (30) days after the date of such notice. An event of Good Reason shall occur automatically at the expiration of such 30-day period if the relevant condition remains uncured at such time.

g. In Connection with a Change of Control. For purposes of this Agreement, a termination of Executive’s employment with Heska is “In Connection with a Change of Control” if Executive’s employment is terminated without Cause or for Good Reason during the period beginning three (3) months prior to a Change of Control and ending eighteen (18) months following a Change of Control.

9. Confidential Information.

a. Executive acknowledges that Executive has executed Heska’s standard employee Confidential Information and Invention Agreement (the “Confidentiality Agreement”). During the Term of Agreement, and for twenty-four (24) months after termination of Executive’s employment, Executive agrees, if requested by Heska, to execute any updated versions of Heska’s form of employee confidential information agreement as may be required of substantially all of Heska’s executive officers.

10.  Executive’s Representations and Warranties.

a. Executive represents and warrants that Executive is not a party to any other employment, non-competition, or other agreement or restriction which could interfere with the Executive’s employment with Heska or Executive’s or Heska’s rights and obligations hereunder and that Executive’s acceptance of employment with Heska and the performance of Executive’s duties hereunder will not breach the provisions of 

.3

any contract, agreement, or understanding to which the Executive is party or any duty owed by the Executive to any other person.

11. Notices.

a. All notices, requests, demands, and other communications called for hereunder will be in writing and will be deemed given:
i. on the date of delivery if delivered personally,
ii. one (1) day after being delivered through a nationally recognized overnight courier service, or
iii. five (5) business days after the date of mailing if sent certified or registered mail.
iv. Notice to Heska shall be sent to its principal place of business with a copy provided by facsimile or electronic communication to the Chair of the Board of Directors, and notice to Executive will be delivered personally or sent to Executive’s last known address provided to Heska.

12. Successors and Assigns.

a. This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors, and legal representatives of Executive upon Executive’s death and (b) any successor of Heska. Any such Successor (as defined below) of Heska will be deemed substituted for Heska under the terms of this Agreement for all purposes. For purposes of this Section, “Successor” means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of Heska. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance, or other disposition of Executive’s right to compensation or other benefits will be null and void.

13. Integration.

a. This Agreement, together with the Confidentiality Agreement, Heska’s stock plans, and Executive’s stock option and restricted stock agreements, represents the entire agreement and understanding between the Parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral, including the Prior Agreement. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing that specifically references this Section and is signed by duly authorized representatives of the Parties hereto.

14. Interpretation.

.3

a. Article titles and section headings contained herein are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. The determination of the terms of, and the drafting of, this Agreement has been by mutual agreement after negotiation, with consideration by and participation of all Parties. Accordingly, the Parties agree that rules relating to the interpretation of contracts against the drafter of any particular clause shall not apply in the case of this Agreement.

15. Waivers.

a. Any term or provision of this Agreement may be waived, or the time for its performance may be extended, by the Party or Parties entitled to the benefit thereof. Any such waiver shall be validly and sufficiently authorized for the purposes of this Agreement if, as to any Party, it is authorized in writing by an authorized representative of such Party. The failure of any Party hereto to enforce at any time any provision of this Agreement shall not be construed to be a waiver of such provision, nor in any way to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each and every such provision. No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach.

16. Severability.

a. If any provision of this Agreement is held illegal, invalid, or unenforceable, such holding shall not affect any other provisions hereof. In the event any provision is held illegal, invalid, or unenforceable, such provision shall be limited so as to give effect to the intent of the Parties to the fullest extent permitted by applicable law. Any claim by Executive against Heska shall not constitute a defense to enforcement by Heska.

17. Tax Matters.

a. Except as provided in Section 6(d) above, Executive agrees that Executive is responsible for any applicable taxes of any nature (including any penalties or interest that may apply to such taxes) that are reasonably determined to apply to any payment made to Executive hereunder (or any arrangement contemplated hereunder), that Executive’s receipt of any benefit hereunder is conditioned on Executive’s satisfaction of any applicable withholding or similar obligations that apply to such benefit, and that any cash payment owed to Executive hereunder will be reduced to satisfy any such withholding or similar obligations that may apply thereto.

b. Executive acknowledges that no representative or agent of Heska has provided Executive with any tax advice of any nature, and Executive has consulted with 

.3

Executive’s own legal, tax, and financial advisor(s) as to tax and related matters concerning the compensation to be received under this Agreement.

18. Section 409A.

a. This Agreement is intended to comply with Section 409A of the Code, as amended (“Section 409A”) and shall be construed accordingly. It is the intention of the parties that payments or benefits payable under this Agreement not be subject to the additional tax or interest imposed pursuant to Section 409A. To the extent such potential payments or benefits are or could become subject to Section 409A, the parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax or interest being imposed; provided, however, that no such amendment shall materially increase the cost to, or impose any liability on Heska with respect to any benefits contemplated or provided hereunder. Executive shall, at the request of Heska, take any reasonable action (or refrain from taking any action), required to comply with any correction procedure promulgated pursuant to Section 409A.

b. If a payment that could be made under this Agreement would be subject to additional taxes and interest under Section 409A, Heska in its sole discretion may accelerate some or all of a payment otherwise payable under the Agreement to the time at which such amount is includible in the income of Executive, provided that such acceleration shall only be permitted to the extent permitted under Treasury Regulation § 1.409A- 3(j)(4)(vii) and the amount of such acceleration does not exceed the amount permitted under Treasury Regulation § 1.409A-3(j)(vii).

c. No payment to be made under this Agreement shall be made at a time earlier than that provided for in this Agreement unless such payment is (i) an acceleration of payment permitted to be made under Treasury Regulation § 1.409A-3(j)(4) or (ii) a payment that would otherwise not be subject to additional taxes and interest under Section 409A.

d. The right to each payment described in this Agreement shall be treated as a right to a series of separate payments and a separately identifiable payment for purposes of Section 409A.

e. For purposes of Section 6 of this Agreement, “termination” (or any similar term) when used in reference to Executive’s employment shall mean “separation from service” with Heska within the meaning of Section 409A(a)(2)(A)(i) of the Code and applicable administrative guidance issued thereunder, and Executive shall be considered to have terminated employment with Heska when, and only when, Executive incurs a “separation from service” with Heska within the meaning of Section 409A(a)(2)(A)(i) of the Code and applicable administrative guidance issued thereunder.

.3

f. If Executive qualifies as a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code and would receive any payment sooner than six (6) months after Executive’s separation from service that, absent the application of this Section 19(f), would be subject to additional tax imposed pursuant to Section 409A as a result of such status as a specified employee, then such payment shall instead be payable on the date that is the earliest of (i) six (6) months after Executive’s separation from service, (ii) Executive’s death, or (iii) such other date as will not result in such payment being subject to such additional tax.

19. Governing Law; Waiver of Jury Trial.

a. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Colorado without regard to conflict of law principles. The Parties hereto each waive their respective rights to a jury trial of any and all such claims and causes of action.

20. Counterparts.

a. This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an original and will constitute an effective, binding agreement on the part of each of the undersigned.

[signature page follows]

.3

IN WITNESS WHEREOF, Heska has caused this Employment Agreement to be duly executed by an officer thereunto duly authorized, and Executive has hereunto set Executive’s hand, all as of the day and year first above written.

EXECUTIVE:

/s/ Steve Eyl
Steve Eyl
Executive Vice President, Chief Commercial Officer, Heska and President, scil animal care company

HESKA CORPORATION:

/s/ Kevin Wilson
Kevin Wilson
Chief Executive Officer and President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00312-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00312-of-00352.parquet"}]]